Marshe, Victoria S. http://orcid.org/0000-0002-1762-4819
Maciukiewicz, Malgorzata
Hauschild, Anne-Christin
Islam, Farhana
Qin, Li
Tiwari, Arun K.
Sibille, Etienne http://orcid.org/0000-0001-5832-6570
Blumberger, Daniel M.
Karp, Jordan F.
Flint, Alastair J.
Turecki, Gustavo http://orcid.org/0000-0003-4075-2736
Lam, Raymond W. http://orcid.org/0000-0001-7142-4669
Milev, Roumen V.
Frey, Benicio N. http://orcid.org/0000-0001-8267-943X
Rotzinger, Susan
Foster, Jane A.
Kennedy, Sidney H. http://orcid.org/0000-0001-5339-7185
Kennedy, James L. http://orcid.org/0000-0002-8733-3806
Mulsant, Benoit H.
Reynolds, Charles F. III
Lenze, Eric J.
Müller, Daniel J. http://orcid.org/0000-0003-4978-4400
Article History
Received: 18 November 2020
Revised: 15 December 2020
Accepted: 7 January 2021
First Online: 15 February 2021
Conflict of interest
: E.J.L. has received funding from Takeda, Lundbeck, Janssen, Alkermes, Aptynx, and PCORI, and is a consultant for Janssen and Jazz Pharmaceuticals. B.H.M. currently receives research support from Brain Canada, the Canadian Institutes of Health Research, the CAMH Foundation, the Patient-Centered Outcomes Research Institute (PCORI), the US National Institute of Health (NIH), Capital Solution Design LLC (software used in a study founded by CAMH Foundation), and HAPPYneuron (software used in a study founded by Brain Canada). He directly owns stocks of General Electric (less than $5,000). Within the past 3 years, he has also received research support from Eli Lilly (medications for an NIH-funded clinical trial) and Pfizer (medications for an NIH-funded clinical trial).